美国IPO周报：两笔小型交易上线，更多交易进入筹备阶段 随着美国政府停摆终于结束，上周有两家小型IPO和三家SPAC上市。五家IPO和四家SPAC提交了初始 申请。 游艇零售商Off The Hook YS(OTH)将其规模缩减的IPO定价在发行价区间的下限，以9500万美元的市值 筹集了1500万美元。该公司声称是业内最大的船舶批发商，拥有八家实体店和线上业务。Off The Hook 还为客户提供融资方案以及配套的船舶服务和维修。该公司上周股价下跌8%。 总部位于新加坡的显微镜技术提供商Phaos Technology(POAS)将其美国IPO定价在发行价区间的下限， 以1.14亿美元的市值筹集了1400万美元。该公司专注于为制造业、生物医学和半导体等行业组装和商业 化先进的显微镜相关解决方案、技术和产品。该公司声称，凭借其专利的微球辅助技术，其提供的唯一 一款商用先进光学显微镜能够在商业可行的工作距离内，实现低于200纳米的光学极限成像。Phaos Technology上周股价持平。 上周递表企业名单 | 9 Filings During the Week of November 10th, 2025 ...

当地时间11月12日晚，美国历史上持续时间最长的政府停摆终于结束，企业进入资本市场通道亦重新开 启。停摆结束的第二日，IPO市场迎来3只新股，共募集资金2.8亿美元，3家新股均在纽交所上市。 1、Phaos Technology(POAS) 首日开盘，Phaos Technology每股报3.7美元，较发行价下跌7.5%。盘中低位盘旋，至收盘每股报3.85美 元，跌幅3.75%，总市值1.09亿美元。 该公司此次以每股4美元，发行了360万股，募集了1440万美元。根据招股书，Phaos Technology计划将 此次募集资金用于营销和推广、产品开发，以及一般营运资金。 Phaos Technology是一家显微镜技术提供商，专注于制造、生物医学和半导体等行业的先进显微镜相关 解决方案、技术和产品的组装和商业化，其产品包括光纳、工业、计量、生物、立体和变焦系列。2025 财年(截至4月30日)，Phaos Technology营收13万美元，净亏损393万美元。 2、Off The Hook(OTH) 首日开盘，Off The Hook每股报3.5美元，较发行价下跌12.5%。盘中震荡，尾盘小幅拉升，至收盘 ...

Core Insights - Eight new stocks were listed last week, including one direct listing company, raising significant capital across various sectors [1][2][3]. Group 1: Recent IPOs - MapLight Therapeutics (MPLT) raised $251 million by issuing 14.75 million shares at $17 each [1]. - Navan (NAVN) raised $923 million by issuing 36.92 million shares at $25 each [1]. - Boyd Group Services (BGSI) raised $780 million by issuing 5.5 million shares at $141 each [2]. - Nomadar (NOMA) entered Nasdaq through a direct listing [3]. Group 2: Upcoming IPOs - BETA Technologies, Inc. plans to list on NYSE with a target date of November 4, 2025, aiming to raise approximately $825 million by issuing 25 million shares at $27 to $33 each. The company reported revenue of $15.57 million in the first half of 2025, up from $7.59 million in the same period last year, with a net loss of $159 million [4][6]. - Exzeo Group, Inc. plans to list on NYSE on November 5, 2025, aiming to raise about $176 million by issuing 8 million shares at $20 to $22 each. The company reported revenue of $109 million in the first half of 2025, up from $60.31 million year-over-year, with a net profit of $39.61 million [6][8]. - Evommune, Inc. plans to list on NYSE on November 6, 2025, aiming to raise approximately $159 million by issuing 9.38 million shares at $15 to $17 each. The company reported revenue of $3 million in the first half of 2025, down from $7 million year-over-year, with a net loss of $28.12 million [10]. - Grupo Aeroméxico, S.A.B. de C.V. plans to list on NYSE on November 6, 2025, aiming to raise about $235 million by issuing 11.73 million shares at $18 to $20 each. The company reported revenue of $2.498 billion in the first half of 2025, down from $2.695 billion year-over-year, with a net profit of $89.97 million [12]. - BillionToOne, Inc. plans to list on NASDAQ on November 6, 2025, aiming to raise approximately $212 million by issuing 3.85 million shares at $49 to $55 each. The company reported revenue of $126 million in the first half of 2025, up from $69.09 million year-over-year, with a net loss of $4.23 million [14]. - Off The Hook YS Inc. plans to list on NYSE MKT on November 7, 2025, aiming to raise about $30 million by issuing 5 million shares at $4 to $6 each. The company reported revenue of $58.59 million in the first half of 2025, up from $51.85 million year-over-year, with a net profit of $840,000 [16].